The difference between $0 and $449 a month for Zepbound is a prior authorisation, and prior authorisation is exactly where most people stop.
LifeMD publishes Zepbound vials from $349 a month self-pay and Wegovy pens from $199, and states branded GLP-1s can be as low as a $0 copay where insurance covers them. The membership is $149 a month after the first month, which makes the cash-pay total about $498 for Zepbound.
Against LillyDirect at $299 to $449 with no membership, that is a poor cash deal. The entire case rests on whether the insurance route works for you.
The exclusion that rules many people out
For commercially insured patients the arithmetic is different and can be dramatic. Coverage for Zepbound is patchy but real, and its approval for obstructive sleep apnoea in adults with obesity occasionally unlocks authorisation where a weight-only request would be refused.
Price it both ways before committing: $498 a month if the authorisation fails, potentially near zero if it succeeds. That spread is the whole decision, and no provider can promise you which side of it you land on.
What it actually costs per year
Advertised prices in this category are usually medication only. Add the membership back in and the ranking changes. Pick a provider, or enter the quote you were given.
One-month semaglutide rate. Starting at $79/month equivalent requires a 12-month plan ($948 total); confirm payment and renewal terms.
- First month
- $139
- Every month after
- $139
- Total over 12 months
- $1,668
No membership on this plan, so every dollar goes to medication and care.
Figures are the providers' own published prices as of our last review of each. Promotional rates, multi-month prepayment and dose changes can all move these numbers — confirm at checkout.
What Zepbound is, and what it costs at source
Zepbound is tirzepatide, approved by FDA for chronic weight management, and it produced the largest average reductions of any drug in this class — roughly 20 to 21% of body weight over 72 weeks at the highest doses. It is also approved for obstructive sleep apnoea in adults with obesity, which occasionally unlocks coverage where a weight-only prescription would be refused.
Eli Lilly sells it directly. LillyDirect publishes single-dose vials at $299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg through 15 mg, with KwikPens across the same range. That is the reference price, and it is close enough to mid-market compounded tirzepatide that the comparison is worth running properly.
Before you buy branded from a reseller
- Check the manufacturer's own price first — NovoCare for Wegovy, LillyDirect for Zepbound. Resale prices range across an order of magnitude.
- Establish whether a membership or programme fee is charged on top of the medication.
- Ask what the price is at your expected maintenance dose, since branded pricing usually rises with dose.
- If you have type 2 diabetes, ask about Ozempic or Mounjaro through insurance before paying cash for anything.
- Confirm whether the provider will submit a prior authorisation, and what happens if it is denied.